Unigestion Holding’s ResMed RMD Stock Holding History

Unigestion Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,318	Closed	-$267K	–	338
2018 Q3	$267K	Sell	2,318 -226	-9%	-$24.8K	0.01%	308
2018 Q2	$264K	Buy	+2,544	New	+$257K	0.01%	312

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Unigestion Holding's RMD Position: Q4 2018 in Review

Unigestion Holding sold out of ResMed (RMD) in Q4 2018, closing a stake of 2,318 shares — an estimated $267K sold.

Unigestion Holding first reported a position in RMD in Q2 2018 and held it in 2 quarters. The position peaked at $267K in Q3 2018. 501 funds tracked by Wall St. Rank hold RMD as of Q4 2018.

Unigestion Holding reported no remaining ResMed position as of Q4 2018 after selling out during the quarter.
Unigestion Holding sold 2,318 ResMed shares in Q4 2018, an estimated $267K.
Unigestion Holding first reported a position in ResMed in Q2 2018 and held it in 2 quarters.
Unigestion Holding's ResMed position peaked at $267K in Q3 2018.
501 funds tracked by Wall St. Rank held ResMed as of Q4 2018.

Based on Unigestion Holding's 13F filing for Q4 2018, filed 8 Feb 2019.